Anthem Bioscienc

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
950.95
13.2 (1.41%)
BSENSE

Nov 20

BSE+NSE Vol: 3.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039665,
    "name": "Anthem Bioscienc",
    "stock_name": "Anthem Bioscienc",
    "full_name": "Anthem Biosciences Ltd",
    "name_url": "stocks-analysis/anthem-bioscienc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "950.95",
    "chg": 13.2,
    "chgp": "1.41%",
    "dir": 1,
    "prev_price": "937.75",
    "mcapval": "52,544.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 544449,
    "symbol": "ANTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0CZ201020",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "3.82 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anthem Biosciences Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/anthem-biosciences-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-4268855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AnthemBioscienc_technicaldot_4268855.png",
        "date": "2026-11-20 08:05:12",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by improvements in key technical indicators and a recent upgrade in its Mojo Grade from Buy to Hold, reflecting a nuanced market outlook as the stock approaches its 52-week high."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-by-marketsmojo-4265256",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AnthemBioscienc_mojoScore_4265256.png",
        "date": "2026-11-17 10:10:50",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 November 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 17 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Anthem Biosciences Gains 2.41%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/anthem-biosciences-gains-241-3-key-factors-driving-the-weeks-momentum-4261229",
        "imagepath": "",
        "date": "2026-11-14 09:01:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> New 52-week and all-time high at Rs.989.15 and Rs.985.95 respectively</p>\n                    <p><strong>Nov 11:</strong> Technical upgrade to bullish momentum amid positive indicators</p>\n                    <p><strong>Nov 12-13:</strong> Mild price correction with declines of 2.02% and 0.22%</p>\n                    <p><strong>Week Close:</strong> Rs.936.40, up 2.41% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.914.35</div>\n                    </div>\n                    <..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Anthem Biosciences Ltd to 52-Week High of Rs 989.15",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/anthem-biosciences-ltd-hits-new-52-week-high-at-rs98915-4256512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AnthemBioscienc_priceRelatedfactors_4256512.png",
        "date": "2026-11-09 09:52:02",
        "description": "With a sustained seven-day rally delivering a 17.33% gain, Anthem Biosciences Ltd surged to a fresh 52-week and all-time high of Rs 989.15 on 09 Nov 2026, outperforming its sector by 2.36% amid mixed market conditions."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Anthem Biosciences Ltd Reaches All-Time High",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/anthem-biosciences-ltd-hits-all-time-high-at-rs98595-on-9-nov-2026-4256458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AnthemBioscienc_priceRelatedfactors_4256458.png",
        "date": "2026-11-09 09:38:11",
        "description": ""
      },
      {
        "title": "Anthem Biosciences Gains 10.37%: 3 Key Factors Driving the Weekly Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/anthem-biosciences-gains-1037-3-key-factors-driving-the-weekly-rally-4254846",
        "imagepath": "",
        "date": "2026-11-07 10:00:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens at Rs.840.55, up 1.46% on strong market sentiment</p>\n                    <p><strong>4 Nov:</strong> Reports record quarterly profitability; stock surges 3.86% to Rs.887.45</p>\n                    <p><strong>5 Nov:</strong> Downgrade to Hold and quality grade lowered; stock still gains 2.94%</p>\n                    <p><strong>6 Nov:</strong> Week closes at Rs.914.35, up 0.09% amid cautious optimism</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.828.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-lab..."
      },
      {
        "title": "Anthem Biosciences Ltd Reports Strong Quarterly Turnaround with Record Profitability",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/anthem-biosciences-ltd-reports-strong-quarterly-turnaround-with-record-profitability-4250747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AnthemBioscienc_fintrenddot_4250747.png",
        "date": "2026-11-04 11:00:40",
        "description": "Anthem Biosciences Ltd has delivered a remarkable financial turnaround in the quarter ended September 2026, reversing a negative trend to post its highest-ever profitability metrics. The mid-cap pharmaceutical and biotechnology company’s latest results highlight robust revenue growth, margin expansion, and improved earnings per share, signalling renewed investor confidence and a positive outlook for the sector."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-4235284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AnthemBioscienc_mojoScore_4235284.png",
        "date": "2026-10-23 10:10:03",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4207754",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AnthemBioscienc_technicaldot_4207754.png",
        "date": "2026-09-29 08:08:17",
        "description": "Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish stance as of late September 2026. Despite a recent dip in price, the stock’s underlying technical indicators present a complex picture, reflecting both resilience and caution within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 61,
    "sid": "10039665",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/anthem-biosciences-10039665"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "06-Nov-2026",
      "details": "Transcript of Q2 & H1 FY27 Earnings Conference Call",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Nov-2026",
      "details": "Intimation of Schedule of Analyst Meet/Institutional Meet",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "05-Nov-2026",
      "details": "Audio recording of Earnings Call for the quarter ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Anthem Biosciences Ltd has declared <strong>100%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

06-Nov-2026 | Source : BSE

Transcript of Q2 & H1 FY27 Earnings Conference Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Nov-2026 | Source : BSE

Intimation of Schedule of Analyst Meet/Institutional Meet

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

05-Nov-2026 | Source : BSE

Audio recording of Earnings Call for the quarter ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Anthem Biosciences Ltd has declared 100% dividend, ex-date: 25 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available